Background: In papillary and follicular thyroid cancers (PTC, FTC), nodal and distant metastasis are generally considered important determinants of recurrence and survival, respectively. However, there is no consensus about the threshold primary tumour size (PTS) for these determinants. The aim of this study was to assess size relationships for developing nodal, pulmonary, bone and overall distant metastases.

Methods: This prospective study covered 139 (93 females and 46 males) consecutive biopsy proven patients with PTC (114/139, mean age 41.0 ± 15.7 years, M: F, 35%:65%) and FTC (25/139, mean age 39.2 ± 14.3 years, M: F: 24%:76%).

Results: Average primary tumor size was 23.4 ± 11.1 mm and 26.5 ± 13.1 mm for PTC and FTC respectively (p value=0.223). Nodal metastasis was found more common in PTC than FTC (49% vs 28%, p value <0.05), whereas overall distant metastasis was approximately the same (13% and 24%, p value =0.277); however, bone metastasis was significantly higher in FTC than PTC (24% vs 5%, p value <0.05). Cumulative risk for nodal and distant metastases for FTC and PTC starts at PTS <20 mm and may indicate an unusual aggressive tumor behavior in the studied population. Highest cumulative risk for nodal and pulmonary metastases in PTC and for bone metastasis in FTC was found to be ≥ 50 mm PTS.

Conclusion: We conclude that a PTS of <20 mm may indicate an unusual aggressive tumor behavior with highest cumulative risk for nodal and pulmonary metastases in PTC and for bone metastasis in FTC with a cutoff of ≥ 50 mm.

Download full-text PDF

Source
http://dx.doi.org/10.7314/apjcp.2012.13.6.2473DOI Listing

Publication Analysis

Top Keywords

ptc ftc
12
threshold primary
8
primary tumour
8
nodal distant
8
papillary follicular
8
follicular thyroid
8
thyroid cancers
8
tumour sizes
4
nodal
4
sizes nodal
4

Similar Publications

Article Synopsis
  • - The case centers on a 67-year-old woman with both papillary and follicular thyroid carcinomas, initially diagnosed with thyrotoxicosis from Graves' disease, presenting with severe metastasis and invasive tumor growth.
  • - Investigation revealed multiple metastases, including intra-cardiac tumor thrombus and bone fractures, leading to a diagnosis of synchronous thyroid cancer types, yet the patient chose palliative care over aggressive treatment options.
  • - The case highlights the challenges in accurately diagnosing synchronous thyroid malignancies and the limitations of the ACR TI-RADS system in detecting certain ultrasonographic features that indicate cancer, especially in patients with Graves' disease.
View Article and Find Full Text PDF

High Expression of Immune Checkpoint Molecules in Different Types of Thyroid Cancer.

Iran J Allergy Asthma Immunol

October 2024

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran AND Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Article Synopsis
  • * Samples from 100 patients with various types of thyroid carcinoma were analyzed, revealing high levels of PD-1 in tumor-infiltrating lymphocytes (88%) and PD-L1 in tumor cells (30%).
  • * Findings showed that increased PD-1 and PD-L1 expression correlates with advanced disease stages and may indicate potential for targeted immunotherapy, particularly in anaplastic thyroid carcinoma.
View Article and Find Full Text PDF

The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer.

Front Oncol

November 2024

Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Thyroid cancer (TC) is the most common endocrine cancer, which contributes to more than 43,600 deaths and 586,000 cases worldwide every year. Among the TC types, PTC and FTC comprise 90% of all TCs. Genetic modifications in genes are responsible for encoding proteins of mitogen-associated protein kinase cascade, which is closely related with numerous cellular mechanisms, including controlling programmed cell death, differentiation, proliferation, gene expression, as well as in genes encoding the PI3K (phosphatidylinositol 3-kinase)/protein kinase B (AKT) cascade, which has contribution in controlling cell motility, adhesion, survival, and glucose metabolism, have been associated with the TC pathogenesis.

View Article and Find Full Text PDF

Thyroid cancer (TC) is one of the most prevalent endocrine malignancy with a steadily increasing incidence globally. Although standard treatments like thyroidectomy and radioiodine therapy effectively manage most cases of differentiated thyroid cancers (DTC), certain recurrent cases or those involving poorly differentiated thyroid cancers (PDTC) demand more specialized interventions. Follicular thyroid cancer (FTC) is the second most common type of DTC, and frequently metastasizes through the bloodstream to distant sites such as bones and lungs which is a leading cause of metastatic and recurrent DTC and significantly affects survival.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effectiveness of the radiotracer [F]SiTATE for imaging thyroid carcinomas (TC), specifically in patients with medullary (MTC) and differentiated (DTC) types, given that data on its use for TC is limited.
  • - A total of 21 patients underwent [F]SiTATE PET/CT scans, analyzing 89 lesions and observing high uptake in metastases, particularly in bone and lymph nodes, while also examining correlations with tumor markers like calcitonin for MTC.
  • - Results suggest that [F]SiTATE PET/CT is a promising tool for imaging thyroid cancer, potentially offering advantages over traditional gallium-based tracers in clinical settings.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!